-
Article
Open AccessErratum: Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Correction to: British Journal of Cancer (2008) 97, 857–861, doi:10.1038/sj.bjc.6603942 The authors of the above paper, first published in October 2007, would like to add the following acknowledgement to their...
-
Article
Immunohistochimie: un progrès majeur pour la classification des CAPI
Carcinoma of unknown primary (CUP) site refers to a metastatic malignant epithelial tumour. Lymph nodes are the most frequently encountered sites, followed by the liver, bones, lungs and brain. CUP is consider...
-
Article
Open AccessCarcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Carcinomas of an unknown primary site (CUP) are heterogeneous tumours with a median survival of only 8 months. Tyrosine kinase inhibitors are promising new drugs. The aim of this study was to determine the exp...
-
Article
Open AccessSummary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)
-
Article
Apport de l’immunohistochimie en pathologie digestive
Parmi les progrès récents réalisés en anatomie pathologique, l’immunohistochimie est au premier plan. Grâce aux nombreux anticorps monoclonaux utilisables sur coupes de tissus fixés, elle est devenue très perf...
